5 бет - Ең жақсы Бас миының МРТ дәрігерлері - ЖОҒ-183 дәрігерлер

EDUCATION:

• Turhan and Mediha Tansel Primary School (1979–1984)
• Kültür College (1984–1988)
• Semiha Şakir High School (1988–1991)
• Marmara University Faculty of Medicine (1991–1997)
• Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
• Title of Associate Professor in Neurosurgery (May 31, 2021)

ADDITIONAL TRAINING:

• "Visiting Physician," University of Southern California, Department of Neurosurgery (1998)
• "Microsurgery Training," GATA (Gülhane Military Medical Academy), Ankara Education and Research Hospital (2003)

PROFESSIONAL EXPERIENCE:

• Gülhane Military Medical Academy Haydarpaşa Training and Research Hospital (2002–2003)
• Dr. Lütfi Kırdar Kartal Training and Research Hospital (2003–2005)
• Private Avicenna Ataşehir Hospital (2005–2012)
• Private 29 Mayıs Hospital (2012–2013)
• Maltepe State Hospital (2013–2018)
• Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)
• Private Academic Hospital (2020–2022)
• Hisar Intercontinental Hospital (2022–2024)
• Private Medipol Acıbadem Regional Hospital (2024–Present)

ADMINISTRATIVE AND ACADEMIC ROLES:

• Board Member, Neurosurgical Society (2006–2009)
• Head of the Emergency Department, Maltepe State Hospital (2014–2016)
• Deputy Chief Physician, Private Academic Hospital (2020–2021)
• Advisory Board Member, Beykent University Faculty of Medicine (2018–2024)
• Faculty Member, Galata University Faculty of Health Sciences (2022–2024)
• Director, Continuous Education Center, Galata University (2022–2024)

Education and Expertise

• 1999 – 2005 – FIRAT UNIVERSITY FACULTY OF MEDICINE
• 1995 – 1999 – IZMIR ATATURK HIGH SCHOOL

Diseases

• Alzheimer’s type dementia
• Headaches
• Dizziness
• Cerebrovascular diseases
• Vascular diseases
• Dementia Diseases
• Demyelinating Diseases
• Epilepsy
• Movement Disorders
• Migraine
• Myopathies
• MOGAD

Treatment Methods

• Botox
• Duodopa Treatment
• Intravenous Thrombolytic
• IVIG Treatment
• Migraine vaccine
• Migraine Botox

Experience

• 2005-2010 – Ege University Faculty of Medicine, Department of Neurology, Specialization Student, Izmir.
• 2010-2012 – İzmir Tire State Hospital Neurology Department
• September 2012 – May 2013 – Çanakkale 18 March University, Faculty of Medicine, Department of Neurology, Assistant Professor.
• 2013 – Medical Point Izmir Hospital Neurology Department

Professional Memberships

• Turkish Neurology Association

Neurologist

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. José Angel Obeso is a world renowned neurologist with over 40 years of experience and 30 years of research in movement disorders. He is the founder of the first specialized Movement Disorders Group of the Spanish Neurology Society and has developed Continuous Dopaminergic Stimulation for Parkinson's disease. He has authored over 350 research articles, and is a member of the American Neurological Association and the International Parkinson and Movement Disorder Society.

Head of the Department of Neurosurgery in the HM Hospitales Clinic

Dr. Abdulkerim Gokoglu is a Neurosurgery Specialist with a PhD in Clinical Anatomy. He is known for his skills in treating brain tumors, spinal diseases, head trauma, congenital nervous system disorders, and spine deformities.

Dr. Gokoglu has broad experience managing stroke, paralysis, aneurysms, hemorrhage, tumors, hernias, and traumatic injuries. He has worked on advanced neurosurgical procedures. He also serves as a postdoctoral research assistant at Brigham and Women’s Hospital, showing his strong focus on both patient care and research.

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Prof. Dr. Gülşah Bademci is a physician specialized in the field of brain, nerve, spine, and spinal cord surgery. She graduated as the fourth-ranked student from Ankara University Faculty of Medicine in 1993. She obtained her title as a brain and nerve surgeon from the Ankara University Faculty of Medicine Department of Brain and Nerve Surgery in 2001. In 2008, she became an associate professor at the Kırıkkale University Faculty of Medicine, and in 2021, she became a professor at the Yüksek İhtisas University Faculty of Medicine. She has contributed to numerous international publications, serving as a research and clinical fellow at the University of Arkansas Medical Sciences with Prof. Dr. M. Gazi Yaşargil, and as a research fellow at Yale University School of Medicine. She holds ECFMG America Board Step 1 and EANS European Board certificates. She speaks advanced-level English and has awards in tennis and swimming. She also pursues professional-level caricature art and medical illustration. In her 30-year career, she has performed numerous surgeries as a brain and nerve surgery specialist, particularly in spinal canal stenosis surgery, lumbar and cervical disc herniations, brain tumors, hydrocephalus surgery, and nerve compressions.

Trustworthy, attentive, successful neurosurgeon with over 34 years of experience, high rate of success and exceptional surgical skills, providing quality neurological service for patients, successfully treating over thousands of patients suffering from many severe, complex conditions of the brain, spine and the nerves. 

Experienced in performing treatment modalities like micro neurosurgery, endoscopic skull base surgery, endoscopic third ventriculostomy, minimally invasive spine surgery and percutaneous spine surgery. Keen on performing clinical research and attending national and international medical conferences to stay abreast of new technologies in the field. Compassionate and detail-oriented with excellent communication skills. Expertise in healthcare, education and program management. Adept at developing and implementing forward-thinking strategies to enhance patient outcomes and collective knowledge in the field. Desiring to bring skills and success. Focused on working closely with other medical professionals and following up with patients. Well-versed at emergency procedures and fast and accurate sanitation.

Work History

2020-01 – Current - Asst. Prof. Neurosurgeon

Istanbul Medipol University, Health Care Practice and Research Center Pendik Hospital

• He successfully treated and followed patients with cerebral hemorrhage, brain and spinal cord tumors, and patients with hydrocephalus.

• He performed transnasal pituitary surgeries with success.

• Also, many cervical lumbar and thoracic disc patients were successfully treated, and disc prosthesis were applied to some of them.

• He re-operated a degenerative spine patient who had been operated on before at another center and the patient regained his health.

• He also successfully treated patients with premature neonatal intracerebral hemorrhage.

2019-08 – 2020-01 - Neurosurgeon

Freelancer, Istanbul, Turkey

• Operated on patients' brains, spines and peripheral nerves to correct deformities, repair injuries, prevent and treat diseases and improve patients' motor functions. Performed successful operations for complex, advanced and complicated disease of the brain and spine some of which were operated unsuccessfully at other medical centers by different neurosurgeons.

• Offered advanced knowledge, leadership abilities and technical assistance with complex surgical cases.

• Maintained admitting privileges at local hospitals and provided quality follow-up care.

• Educated patients on recovery methods and times.

• Designed treatment plans for patients.

• Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Founded a spinal surgery group with orthopedic surgeons and treated very advanced and severe vertebra deformities, spine abnormalities, scoliosis.

2018-12 - 2019-08 - Neurosurgeon

Alkafeel Super Speciality Hospital, Karbala, Iraq

• Conducted up to 5 operations per month to correct deformities in neurological and spinal systems, repair traumas, and treat diseases of different areas. Performed successful operations (success rate 100 percent : 90-95) for severe, complex and advanced diseases of the brain, spine and nerves in adults and children. (Cerebral intrinsic and extrinsic tumor surgery, posterior fossa surgery, spontaneous and traumatic intracranial hematomas, Interhemispheric 3th ventricle and lateral ventricle surgery, pontocerebellar angle tumor surgery, spinal instrumentation and fusion surgery, microdiscectomy cervical, thoracic, lumbar, pediatric cranial and spine anomaly surgery). Followed the patients postoperatively.

• Educated patients on recovery methods and times.

• Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Performed emergency surgeries.

• Examined 900 patients in total in the outpatient clinic and gave medical treatments to them when necessary.

2015-10 - 2018-11 - Neurosurgeon

Medistate Kavacık Hospital, Istanbul, Turkey

• Operated on patients' brains, spines and peripheral nerves to correct deformities, repair injuries, prevent and treat different advanced, complex severe diseases and improve patients' motor functions.

• Conducted up to operations per month to correct deformities in neurological and spinal systems, repair traumas, restore partial or full functionality and prevent and treat diseases of different areas. 

• Performed successful operations (success rate percent : 95) for severe, complex and advanced diseases of the brain , spine and nerves in adults and children.(Brain tumor, arachnoid cyst, intracerebral hematoma, spinal stenosis, hydrocephalus, myelomeningocele).Followed the patients postoperatively. 

• Educated patients on recovery methods and times Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Performed emergency surgeries (intracerebral hematoma, intracerebral abscess).

• Examined 850 patients in total in the outpatient clinic and gave medical treatment to them when necessary.

1994-03 - 2015-09 - Neurosurgeon

Ankara Training and Research Hospital, Ankara, Turkey

• Supervised trainees, medical students, residents and fellows to help each achieve proficiency in field.

• Conducted up to 20 operations per month to correct deformities in neurological and spinal systems, repair traumas, restore partial or full functionality and prevent and treat diseases of different areas. Performed successful operations (success rate: %90) for severe, complex and advanced diseases of the brain, spine and nerves in adults and children. (Skull base surgery, extended trans base approach, orbit zygomatic approach, presigmoid approach, orbital approaches, transcranial and lateral orbitotomy, Endoscopic transsphenoidal pituitary surgery, CSF leakage surgery, endoscopic, microscopic and transsphenoidal, transcranial. Endoscopic third ventriculostomy and surgery of multiloculated hydrocephalus and pediatric neurosurgery. Cerebral intrinsic and extrinsic tumor surgery, posterior fossa surgery. Brain aneurysm, AVM and cavernoma surgery.

• Spontaneous and traumatic intracranial hematomas. Hemifacial spasm and trigeminal neuralgia surgery (microsurgical decompression) Interhemispheric 3th ventricle and lateral ventricle surgery. Pineal area surgery. Pontocerebellar angle tumor surgery.

• Foreman magnum tumors surgery. Surgery of hydrocephaly, Syringomyelia and craniovertebral animalia).Followed the patients postoperatively.

• Educated patients on recovery methods and times Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Performed emergency surgeries (Epidural, subdural and intracerebral hematoma, vertebra fracture).

• Examined 500-700 patients per day in the outpatient clinic and gave medical treatment to them when necessary. Examined patients in the emergency service.

• Designed treatment plans for patients.

• Offered advanced knowledge, leadership abilities and technical assistance with complex surgical cases.

• Led and oversaw 15 medical personnel in operating room setting to perform surgeries.

• Led and oversaw medical personnel in operating room setting to perform surgeries.

Education

1982-09 - 1988-08

M.D.: Medicine And (Pre-Medicine)

Ankara University Medical School - Ankara

General Medicine Training for 6 years. Graduated with a high GPA.

1988-11 - 1994-05

Specialist Neurosurgery: Neuroscience

University of Health Sciences - Ankara

6 years of neurosurgery training.

• My thesis was on brain abscess and their clinical and laboratory evaluations

1995-05 - 1995-07

Neuroscience

The Institute of Neurological Sciences and Psychiatry.

Ankara

I attended the course for microsurgery at University of Hacettepe Institute of Neurological Sciences and Psychiatry.

1998-04 - 2019-05

Observer Doctor: Neuroscience

Department of Neurosurgery, MSU - Ann Arbour, 

Michigan USA

2012-05 - 2012-05

Neuro endoscopy: Neuroscience

Ghent University - Ghent, Belgium

International endoscopic neurosurgery workshop, 

Ghent, Belgium

I attended the workshop for endoscopic skull base operations the and Neuro endoscopic third ventriculostomy at University of Ghent Hospital

Skills

Micro neurosurgery - Excellent

Neuro endoscopy - Excellent

Cranial base endoscopy - Excellent

Minimal invasive surgery - Excellent

Percutaneous spinal surgery - Excellent

Neuronavigation – Excellent

Certifications

1995-04 Microsurgery

2012-05 Endoscopy

Languages

Turkish - Native

English - Advanced

Arabic - Novice

Affiliations

Turkish Neurosurgical Society

Turkish Medical Association

Accomplishments

• Trained team of staff nurses in medical office procedures to ensure consistent quality of care.

• Published 17 articles in national and international reviews and presented papers in medical congresses.

Interests and operations I perform

Vascular diseases of brain

Endoscopic hypophysis surgery

Tumors of brain, spine and medulla spinalis surgery

Endoscopic brain ventricle surgery

Endoscopic third ventriculostomy 

Traumas of brain and spine

Cervical, thoracic and lumbar disc hernias and narrow 

canal disease surgery

Spine instrumentation and fusion surgery

Baclofen pump and neurostimulators insertions

Hydrocephalus surgery

Congenital diseases of the brain and spine (pediatric 

neurosurgery)

Peripheral nerve surgery

Доктор Виола Фокс BKZ Золингендегі Гематология, Онкология және Паллиативтік медицина клиникасының бас дәрігері болып табылады. Бұл клиника сертификатталған пәнаралық қатерлі ісік орталығы. Доктор Фокс ісік ауруларын дәрі-дәрмекпен емдеуде Германия мен Еуропадағы жетекші сарапшы болып табылады. Ол осы салада 15 жылдан астам тәжірибесі бар.

Ол Германияның Онкология және Гематология-онкология Қоғамының (GDHO), Германия Дәрігерлер қауымдастығының және Американдық Қатерлі Ісік Зерттеу Қауымдастығының мүшесі болып табылады. Доктор Фокс молекулалық биология бойынша да зерттеулер жүргізеді. Оның жұмысы қатерлі ісікті емдеу мен молекулалық диагностика саласының алға жылжыуына қолдау көрсетеді.

Оның негізгі маманданған салалары химиотерапия, иммунотерапия, мақсатты терапия және радиациялық терапия болып табылады. Доктор Фокс инновациялық әдістері мен пациенттерге қамқорлық жасаудағы жоғары құлшынысымен танымал. Оның күш-жігері жоғары қалпына келу көрсеткіштерімен және әріптестерінің мойындауымен ерекшеленеді.

Проф. Илхан Елмажы – жетекші нейрохирург. Ол мидың және омыртқаның ісіктерін, нейроонкологияны, бас сүйек негізін хирургиялау бойынша шеберлігімен танымал. Ол Джон Хопкинс университеті сияқты үздік мекемелерде жұмыс істеген. Доктор Елмажы микроскопиялық хирургия мен эндоскопиялық бас сүйек негізі операцияларының жаңа әдістерін енгізген.

Ол Түркиядағы Бас сүйек негізі қоғамының негізін қалаушы төрағасы. Сондай-ақ, Еуропалық Бас сүйек негізі қоғамының белсенді мүшесі. Доктор Елмажы мамандықтары аралық топтық жұмыс арқылы нейрохирургияны дамытуға үлес қосты. Ол Түркиядағы ЕANS аккредитацияланған алғашқы нейрохирургиялық клиниканы басқарды. Ол сондай-ақ Еуропалық нейрохирургиялық қоғамдар қауымдастығының аккредитацияларына ие.

Доктор Елмажы 110-нан астам ғылыми мақала жариялаған және 250-ден астам баяндамалар жасаған. Оның жұмысы әлем бойынша нейрохирургиялық тәжірибеге және пациенттердің күтіміне әсер етуді жалғастыруда.

Доктор Гүлсен Көсе – 40 жылдан астам тәжірибесі бар беделді педиатриялық невропатолог. Түркияда педиатриялық невропатологияның дамуына маңызды рөл атқарды. 1993 жылы Анкара Балалар Денсаулығы және Гематология Онкология Ауруханасында Педиатриялық Невропатология Бөлімінің құрылуына көмектесті. Оның жұмысы науқастарды күту бойынша жаңа стандарттарды белгіледі.

Доктор Көсе нейродегенеративті, нейрометаболикалық және сирек кездесетін невропатологиялық ауруларға маманданған. Автоиммундық энцефалит және SSPE бойынша ерекше біліктілігі бар. Эпилепсия, фебрильді талмалар және церебральды параличпен жұмысымен де белгілі. Оның күтімі мыңдаған балалардың өмірін жақсартты.

Доктор Көсе - Түрік Дамуышы Педиатриялық Невропатология Қоғамының негізін қалаушы мүшесі. Сондай-ақ, бес негізгі халықаралық педиатриялық невропатология қоғамдарында белсенді. Клиника бастығы және ассистент профессор ретінде елде клиникалық хаттамалар мен мамандарды дайындауға әсер етті.

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Born in Mucur district of Kırşehir, Firdevs Seyfe Şen completed her primary, secondary and high school education in Kırşehir and then entered Adana Çukurova University Faculty of Medicine in 1987. After graduating in 1993, she started to work as a general practitioner in Kırşehir province Kaman district No. 1 health center to do her compulsory service. After 1 year, he was assigned to Kırşehir State Hospital Emergency Department. Then he assumed the duty of Kırşehir Provincial Health Directorate Mental and Mental Health Branch Directorate. In 1996, he became a specialty student at Manisa Celal Bayar University Faculty of Medicine, Department of Mental Health and Diseases with TUS. He successfully presented his thesis titled "Attitudes of people living in a rural area in Turkey towards depression" and became a Psychiatrist.

His first place of duty as a mental health and diseases specialist was Manisa Turgutlu State Hospital. Here he managed the psychiatry clinic for over 10 years. In accordance with the legislation of the Ministry of Health, he worked as a private practice physician for a period.

He became a Psychodrama Therapist at Abdülkadir Özbek Psychodrama Institute. She received individual Psychoanalysis training from Assoc. Prof. Dr. Ayhan Eğrilmez, social skills training in Schizophrenia from Prof. Dr. Mustafa Yıldız, Motivational interviewing training from Prof. Dr. Kültegin Ögel.

She successfully completed the Psychoanalytically Oriented Group Psychotherapy and Psychoanalysis Training organized by Halime Odağ Psychoanalysis and Psychotherapy Foundation and Prof. Dr. Vamık Volkan's Use of Dreams in Psychoanalysis Training.

Other trainings she has successfully completed are 1st and 2nd Level EMDR Basic Training and CETAD Basic Training organized by EMDR Association. After completing BDP Association, Cognitive and Behavioral Therapy Theoretical Training from Prof. Dr. M Hakan Türkçapar, he completed the Driver Behavior Improvement Training and Substance Abuse Physician Training organized by the Ministry of Health with certification.

In 2020, he retired from the public sector at his own request and started to work as a psychiatry specialist in Izmir Nöron Psychiatry Branch Center, where he is a founding partner. Here, he completed TMU trainings in addition to his interests for 2 years and became a pioneer in TMU treatment in Izmir province.

As of February 2022, he decided to continue his education, knowledge and professional experience at Üsküdar University NP Brain Hospital and started to work.

Psychotic Disorders, Depression, Anxiety Disorders, Panic Disorder, Obsessive Compulsive Disorder, Test Anxiety are her special interests.